Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.4 - $0.67 $1,120 - $1,877
-2,802 Reduced 39.18%
4,350 $1,000
Q1 2023

May 12, 2023

SELL
$0.56 - $2.82 $34,419 - $173,325
-61,463 Reduced 89.58%
7,152 $4,000
Q4 2022

Feb 08, 2023

BUY
$0.48 - $16.88 $28,591 - $1.01 Million
59,566 Added 658.26%
68,615 $185,000
Q3 2022

Nov 10, 2022

SELL
$1.44 - $13.52 $20,507 - $192,538
-14,241 Reduced 61.15%
9,049 $14,000
Q2 2022

Aug 10, 2022

SELL
$2.52 - $14.42 $3,283 - $18,789
-1,303 Reduced 5.3%
23,290 $59,000
Q1 2022

May 16, 2022

SELL
$12.69 - $20.72 $87,561 - $142,968
-6,900 Reduced 21.91%
24,593 $341,000
Q4 2021

Feb 14, 2022

BUY
$19.7 - $23.71 $125,567 - $151,127
6,374 Added 25.38%
31,493 $652,000
Q3 2021

Nov 15, 2021

BUY
$21.32 - $29.36 $25,690 - $35,378
1,205 Added 5.04%
25,119 $560,000
Q2 2021

Aug 13, 2021

BUY
$17.01 - $24.14 $3,027 - $4,296
178 Added 0.75%
23,914 $565,000
Q1 2021

May 12, 2021

BUY
$21.8 - $36.52 $304,437 - $510,001
13,965 Added 142.92%
23,736 $571,000
Q4 2020

Feb 11, 2021

BUY
$23.44 - $31.85 $55,716 - $75,707
2,377 Added 32.15%
9,771 $262,000
Q3 2020

Nov 12, 2020

SELL
$25.1 - $53.8 $116,363 - $249,416
-4,636 Reduced 38.54%
7,394 $215,000
Q2 2020

Jul 31, 2020

BUY
$16.0 - $40.99 $51,744 - $132,561
3,234 Added 36.77%
12,030 $493,000
Q1 2020

May 01, 2020

SELL
$7.79 - $19.91 $92,895 - $237,426
-11,925 Reduced 57.55%
8,796 $166,000
Q4 2019

Feb 14, 2020

BUY
$8.01 - $12.48 $63,983 - $99,690
7,988 Added 62.73%
20,721 $252,000
Q3 2019

Nov 14, 2019

BUY
$8.7 - $23.46 $100,528 - $271,080
11,555 Added 980.9%
12,733 $120,000
Q2 2019

Aug 14, 2019

BUY
$15.75 - $23.0 $9,119 - $13,317
579 Added 96.66%
1,178 $27,000
Q1 2019

May 14, 2019

SELL
$16.02 - $22.17 $30,870 - $42,721
-1,927 Reduced 76.29%
599 $12,000
Q4 2018

Feb 14, 2019

BUY
$15.98 - $21.0 $40,365 - $53,046
2,526 New
2,526 $50,000

Others Institutions Holding VAPO

About VAPOTHERM INC


  • Ticker VAPO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,697,200
  • Market Cap $57.9M
  • Description
  • Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...
More about VAPO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.